A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
Clinical trial NCT02246621 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02246621
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-06
- Primary completion
- 2017-01-31
- Enrollment
- 493
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.